Satsuma Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Satsuma Pharmaceuticals

09/11/2021 22:42

* Satsuma Pharmaceuticals Inc  STSA.OQ  reported a quarterly
adjusted loss of 42 cents​​ per share for the quarter ended in
September. The mean expectation of three analysts for the
quarter was for a loss of 51 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Satsuma Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 42 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Satsuma Pharmaceuticals Inc shares had risen by 29.4% this
quarter and gained 30.8% so far this year.
* The company reported a quarterly loss of $13.33 million.
* Wall Street's median 12-month price target for Satsuma
Pharmaceuticals Inc is $15.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 10:41 p.m.
 ​All figures in US dollars unless otherwise stated